nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—ABCC3—Methotrexate—psoriatic arthritis	0.112	0.156	CbGbCtD
Lamivudine—ABCC4—Methotrexate—psoriatic arthritis	0.0854	0.119	CbGbCtD
Lamivudine—ABCC1—Methotrexate—psoriatic arthritis	0.0687	0.096	CbGbCtD
Lamivudine—ABCC2—Dexamethasone—psoriatic arthritis	0.0632	0.0884	CbGbCtD
Lamivudine—ABCG2—Dexamethasone—psoriatic arthritis	0.0572	0.0799	CbGbCtD
Lamivudine—ABCB1—Methylprednisolone—psoriatic arthritis	0.0545	0.0762	CbGbCtD
Lamivudine—ABCC2—Methotrexate—psoriatic arthritis	0.0508	0.071	CbGbCtD
Lamivudine—ABCG2—Methotrexate—psoriatic arthritis	0.0459	0.0642	CbGbCtD
Lamivudine—SLC22A6—Methotrexate—psoriatic arthritis	0.0372	0.052	CbGbCtD
Lamivudine—ABCB1—Betamethasone—psoriatic arthritis	0.0354	0.0495	CbGbCtD
Lamivudine—ABCB1—Prednisolone—psoriatic arthritis	0.035	0.0489	CbGbCtD
Lamivudine—ABCB1—Prednisone—psoriatic arthritis	0.033	0.0462	CbGbCtD
Lamivudine—ABCB1—Dexamethasone—psoriatic arthritis	0.0206	0.0288	CbGbCtD
Lamivudine—ABCB1—Methotrexate—psoriatic arthritis	0.0166	0.0232	CbGbCtD
Lamivudine—NME1—Fluticasone Propionate—Methylprednisolone—psoriatic arthritis	0.000676	0.0876	CbGdCrCtD
Lamivudine—NME1—Fluticasone Propionate—Betamethasone—psoriatic arthritis	0.000665	0.0862	CbGdCrCtD
Lamivudine—NME1—Fluticasone Propionate—Dexamethasone—psoriatic arthritis	0.000665	0.0862	CbGdCrCtD
Lamivudine—NME1—Fluticasone Propionate—Triamcinolone—psoriatic arthritis	0.00065	0.0842	CbGdCrCtD
Lamivudine—DCK—Desoximetasone—Methylprednisolone—psoriatic arthritis	0.000448	0.058	CbGdCrCtD
Lamivudine—DCK—Desoximetasone—Dexamethasone—psoriatic arthritis	0.000441	0.0571	CbGdCrCtD
Lamivudine—DCK—Desoximetasone—Betamethasone—psoriatic arthritis	0.000441	0.0571	CbGdCrCtD
Lamivudine—DCK—Diflorasone—Methylprednisolone—psoriatic arthritis	0.000434	0.0563	CbGdCrCtD
Lamivudine—DCK—Desoximetasone—Triamcinolone—psoriatic arthritis	0.000431	0.0558	CbGdCrCtD
Lamivudine—DCK—Diflorasone—Betamethasone—psoriatic arthritis	0.000428	0.0554	CbGdCrCtD
Lamivudine—DCK—Diflorasone—Dexamethasone—psoriatic arthritis	0.000428	0.0554	CbGdCrCtD
Lamivudine—DCK—Diflorasone—Triamcinolone—psoriatic arthritis	0.000418	0.0542	CbGdCrCtD
Lamivudine—DCK—Desoximetasone—Prednisone—psoriatic arthritis	0.000409	0.053	CbGdCrCtD
Lamivudine—DCK—Desoximetasone—Prednisolone—psoriatic arthritis	0.000399	0.0517	CbGdCrCtD
Lamivudine—DCK—Diflorasone—Prednisone—psoriatic arthritis	0.000397	0.0514	CbGdCrCtD
Lamivudine—DCK—Diflorasone—Prednisolone—psoriatic arthritis	0.000387	0.0502	CbGdCrCtD
Lamivudine—Angioedema—Betamethasone—psoriatic arthritis	0.000323	0.00117	CcSEcCtD
Lamivudine—Stomatitis—Methotrexate—psoriatic arthritis	0.000321	0.00116	CcSEcCtD
Lamivudine—Confusional state—Methylprednisolone—psoriatic arthritis	0.00032	0.00116	CcSEcCtD
Lamivudine—Immune system disorder—Prednisone—psoriatic arthritis	0.00032	0.00116	CcSEcCtD
Lamivudine—Malaise—Betamethasone—psoriatic arthritis	0.000319	0.00115	CcSEcCtD
Lamivudine—Malaise—Dexamethasone—psoriatic arthritis	0.000319	0.00115	CcSEcCtD
Lamivudine—Oedema—Triamcinolone—psoriatic arthritis	0.000318	0.00115	CcSEcCtD
Lamivudine—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000318	0.00115	CcSEcCtD
Lamivudine—Vertigo—Betamethasone—psoriatic arthritis	0.000318	0.00115	CcSEcCtD
Lamivudine—Vertigo—Dexamethasone—psoriatic arthritis	0.000318	0.00115	CcSEcCtD
Lamivudine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000318	0.00115	CcSEcCtD
Lamivudine—Syncope—Betamethasone—psoriatic arthritis	0.000317	0.00115	CcSEcCtD
Lamivudine—Syncope—Dexamethasone—psoriatic arthritis	0.000317	0.00115	CcSEcCtD
Lamivudine—Infection—Triamcinolone—psoriatic arthritis	0.000316	0.00114	CcSEcCtD
Lamivudine—Sweating—Methotrexate—psoriatic arthritis	0.000316	0.00114	CcSEcCtD
Lamivudine—Infection—Methylprednisolone—psoriatic arthritis	0.000316	0.00114	CcSEcCtD
Lamivudine—Shock—Triamcinolone—psoriatic arthritis	0.000313	0.00113	CcSEcCtD
Lamivudine—Insomnia—Prednisolone—psoriatic arthritis	0.000313	0.00113	CcSEcCtD
Lamivudine—Alopecia—Prednisone—psoriatic arthritis	0.000313	0.00113	CcSEcCtD
Lamivudine—Shock—Methylprednisolone—psoriatic arthritis	0.000312	0.00113	CcSEcCtD
Lamivudine—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000312	0.00113	CcSEcCtD
Lamivudine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000311	0.00112	CcSEcCtD
Lamivudine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000311	0.00112	CcSEcCtD
Lamivudine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000311	0.00112	CcSEcCtD
Lamivudine—Epistaxis—Methotrexate—psoriatic arthritis	0.000311	0.00112	CcSEcCtD
Lamivudine—Paraesthesia—Prednisolone—psoriatic arthritis	0.000311	0.00112	CcSEcCtD
Lamivudine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000308	0.00111	CcSEcCtD
Lamivudine—Erythema—Prednisone—psoriatic arthritis	0.000308	0.00111	CcSEcCtD
Lamivudine—Malnutrition—Prednisone—psoriatic arthritis	0.000308	0.00111	CcSEcCtD
Lamivudine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000308	0.00111	CcSEcCtD
Lamivudine—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000308	0.00111	CcSEcCtD
Lamivudine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000307	0.00111	CcSEcCtD
Lamivudine—Convulsion—Betamethasone—psoriatic arthritis	0.000307	0.00111	CcSEcCtD
Lamivudine—Convulsion—Dexamethasone—psoriatic arthritis	0.000307	0.00111	CcSEcCtD
Lamivudine—Myalgia—Dexamethasone—psoriatic arthritis	0.000301	0.00109	CcSEcCtD
Lamivudine—Myalgia—Betamethasone—psoriatic arthritis	0.000301	0.00109	CcSEcCtD
Lamivudine—Anxiety—Dexamethasone—psoriatic arthritis	0.0003	0.00108	CcSEcCtD
Lamivudine—Anxiety—Betamethasone—psoriatic arthritis	0.0003	0.00108	CcSEcCtD
Lamivudine—Discomfort—Dexamethasone—psoriatic arthritis	0.000298	0.00108	CcSEcCtD
Lamivudine—Discomfort—Betamethasone—psoriatic arthritis	0.000298	0.00108	CcSEcCtD
Lamivudine—Hypotension—Methylprednisolone—psoriatic arthritis	0.000297	0.00107	CcSEcCtD
Lamivudine—Pain—Prednisolone—psoriatic arthritis	0.000296	0.00107	CcSEcCtD
Lamivudine—Hepatitis—Methotrexate—psoriatic arthritis	0.000296	0.00107	CcSEcCtD
Lamivudine—Pharyngitis—Methotrexate—psoriatic arthritis	0.000294	0.00106	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00029	0.00105	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000289	0.00105	CcSEcCtD
Lamivudine—Oedema—Betamethasone—psoriatic arthritis	0.000289	0.00104	CcSEcCtD
Lamivudine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000289	0.00104	CcSEcCtD
Lamivudine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000289	0.00104	CcSEcCtD
Lamivudine—Oedema—Dexamethasone—psoriatic arthritis	0.000289	0.00104	CcSEcCtD
Lamivudine—Insomnia—Triamcinolone—psoriatic arthritis	0.000288	0.00104	CcSEcCtD
Lamivudine—Insomnia—Methylprednisolone—psoriatic arthritis	0.000287	0.00104	CcSEcCtD
Lamivudine—Infection—Dexamethasone—psoriatic arthritis	0.000287	0.00104	CcSEcCtD
Lamivudine—Infection—Betamethasone—psoriatic arthritis	0.000287	0.00104	CcSEcCtD
Lamivudine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000286	0.00103	CcSEcCtD
Lamivudine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000286	0.00103	CcSEcCtD
Lamivudine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000285	0.00103	CcSEcCtD
Lamivudine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000285	0.00103	CcSEcCtD
Lamivudine—Anaemia—Prednisone—psoriatic arthritis	0.000285	0.00103	CcSEcCtD
Lamivudine—Shock—Dexamethasone—psoriatic arthritis	0.000284	0.00103	CcSEcCtD
Lamivudine—Shock—Betamethasone—psoriatic arthritis	0.000284	0.00103	CcSEcCtD
Lamivudine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000284	0.00103	CcSEcCtD
Lamivudine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000283	0.00102	CcSEcCtD
Lamivudine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000283	0.00102	CcSEcCtD
Lamivudine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000283	0.00102	CcSEcCtD
Lamivudine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000283	0.00102	CcSEcCtD
Lamivudine—Angioedema—Prednisone—psoriatic arthritis	0.000282	0.00102	CcSEcCtD
Lamivudine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00028	0.00101	CcSEcCtD
Lamivudine—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00028	0.00101	CcSEcCtD
Lamivudine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00028	0.00101	CcSEcCtD
Lamivudine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000279	0.00101	CcSEcCtD
Lamivudine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000279	0.00101	CcSEcCtD
Lamivudine—Malaise—Prednisone—psoriatic arthritis	0.000278	0.001	CcSEcCtD
Lamivudine—Vertigo—Prednisone—psoriatic arthritis	0.000277	0.001	CcSEcCtD
Lamivudine—Syncope—Prednisone—psoriatic arthritis	0.000276	0.000998	CcSEcCtD
Lamivudine—Anorexia—Betamethasone—psoriatic arthritis	0.000275	0.000994	CcSEcCtD
Lamivudine—Anorexia—Dexamethasone—psoriatic arthritis	0.000275	0.000994	CcSEcCtD
Lamivudine—Urticaria—Prednisolone—psoriatic arthritis	0.000275	0.000993	CcSEcCtD
Lamivudine—Fatigue—Triamcinolone—psoriatic arthritis	0.000274	0.000991	CcSEcCtD
Lamivudine—Fatigue—Methylprednisolone—psoriatic arthritis	0.000274	0.000989	CcSEcCtD
Lamivudine—Pain—Triamcinolone—psoriatic arthritis	0.000272	0.000983	CcSEcCtD
Lamivudine—Loss of consciousness—Prednisone—psoriatic arthritis	0.000271	0.000978	CcSEcCtD
Lamivudine—Hypotension—Betamethasone—psoriatic arthritis	0.00027	0.000975	CcSEcCtD
Lamivudine—Hypotension—Dexamethasone—psoriatic arthritis	0.00027	0.000975	CcSEcCtD
Lamivudine—Immune system disorder—Methotrexate—psoriatic arthritis	0.000267	0.000965	CcSEcCtD
Lamivudine—Convulsion—Prednisone—psoriatic arthritis	0.000267	0.000964	CcSEcCtD
Lamivudine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000267	0.000963	CcSEcCtD
Lamivudine—Chills—Methotrexate—psoriatic arthritis	0.000265	0.000959	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000263	0.00095	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000263	0.00095	CcSEcCtD
Lamivudine—Arthralgia—Prednisone—psoriatic arthritis	0.000262	0.000948	CcSEcCtD
Lamivudine—Myalgia—Prednisone—psoriatic arthritis	0.000262	0.000948	CcSEcCtD
Lamivudine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000262	0.000947	CcSEcCtD
Lamivudine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000262	0.000945	CcSEcCtD
Lamivudine—Anxiety—Prednisone—psoriatic arthritis	0.000261	0.000944	CcSEcCtD
Lamivudine—Alopecia—Methotrexate—psoriatic arthritis	0.000261	0.000944	CcSEcCtD
Lamivudine—Insomnia—Betamethasone—psoriatic arthritis	0.000261	0.000944	CcSEcCtD
Lamivudine—Insomnia—Dexamethasone—psoriatic arthritis	0.000261	0.000944	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000261	0.000941	CcSEcCtD
Lamivudine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00026	0.000938	CcSEcCtD
Lamivudine—Paraesthesia—Betamethasone—psoriatic arthritis	0.000259	0.000937	CcSEcCtD
Lamivudine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000259	0.000937	CcSEcCtD
Lamivudine—Discomfort—Prednisone—psoriatic arthritis	0.000259	0.000936	CcSEcCtD
Lamivudine—Erythema—Methotrexate—psoriatic arthritis	0.000258	0.00093	CcSEcCtD
Lamivudine—Malnutrition—Methotrexate—psoriatic arthritis	0.000258	0.00093	CcSEcCtD
Lamivudine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000255	0.000921	CcSEcCtD
Lamivudine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000254	0.000918	CcSEcCtD
Lamivudine—Dyspepsia—Betamethasone—psoriatic arthritis	0.000254	0.000918	CcSEcCtD
Lamivudine—Urticaria—Triamcinolone—psoriatic arthritis	0.000253	0.000913	CcSEcCtD
Lamivudine—Urticaria—Methylprednisolone—psoriatic arthritis	0.000252	0.000911	CcSEcCtD
Lamivudine—Dysgeusia—Methotrexate—psoriatic arthritis	0.000252	0.000911	CcSEcCtD
Lamivudine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000252	0.000909	CcSEcCtD
Lamivudine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000252	0.000908	CcSEcCtD
Lamivudine—Oedema—Prednisone—psoriatic arthritis	0.000252	0.000908	CcSEcCtD
Lamivudine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000251	0.000907	CcSEcCtD
Lamivudine—Decreased appetite—Betamethasone—psoriatic arthritis	0.000251	0.000907	CcSEcCtD
Lamivudine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000251	0.000907	CcSEcCtD
Lamivudine—Infection—Prednisone—psoriatic arthritis	0.00025	0.000903	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000249	0.000901	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000249	0.000901	CcSEcCtD
Lamivudine—Back pain—Methotrexate—psoriatic arthritis	0.000249	0.0009	CcSEcCtD
Lamivudine—Fatigue—Betamethasone—psoriatic arthritis	0.000249	0.000899	CcSEcCtD
Lamivudine—Fatigue—Dexamethasone—psoriatic arthritis	0.000249	0.000899	CcSEcCtD
Lamivudine—Shock—Prednisone—psoriatic arthritis	0.000247	0.000894	CcSEcCtD
Lamivudine—Pain—Dexamethasone—psoriatic arthritis	0.000247	0.000892	CcSEcCtD
Lamivudine—Pain—Betamethasone—psoriatic arthritis	0.000247	0.000892	CcSEcCtD
Lamivudine—Nervous system disorder—Prednisone—psoriatic arthritis	0.000247	0.000891	CcSEcCtD
Lamivudine—Skin disorder—Prednisone—psoriatic arthritis	0.000244	0.000882	CcSEcCtD
Lamivudine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000243	0.000878	CcSEcCtD
Lamivudine—Anorexia—Prednisone—psoriatic arthritis	0.00024	0.000866	CcSEcCtD
Lamivudine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000239	0.000863	CcSEcCtD
Lamivudine—Anaemia—Methotrexate—psoriatic arthritis	0.000238	0.00086	CcSEcCtD
Lamivudine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000238	0.00086	CcSEcCtD
Lamivudine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000238	0.00086	CcSEcCtD
Lamivudine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000236	0.000853	CcSEcCtD
Lamivudine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000236	0.000853	CcSEcCtD
Lamivudine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000235	0.000847	CcSEcCtD
Lamivudine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000234	0.000845	CcSEcCtD
Lamivudine—Malaise—Methotrexate—psoriatic arthritis	0.000232	0.000839	CcSEcCtD
Lamivudine—Vertigo—Methotrexate—psoriatic arthritis	0.000231	0.000836	CcSEcCtD
Lamivudine—Leukopenia—Methotrexate—psoriatic arthritis	0.000231	0.000833	CcSEcCtD
Lamivudine—Urticaria—Dexamethasone—psoriatic arthritis	0.000229	0.000829	CcSEcCtD
Lamivudine—Urticaria—Betamethasone—psoriatic arthritis	0.000229	0.000829	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000229	0.000828	CcSEcCtD
Lamivudine—Dizziness—Prednisolone—psoriatic arthritis	0.000229	0.000827	CcSEcCtD
Lamivudine—Asthenia—Triamcinolone—psoriatic arthritis	0.000228	0.000825	CcSEcCtD
Lamivudine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000228	0.000825	CcSEcCtD
Lamivudine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000228	0.000825	CcSEcCtD
Lamivudine—Body temperature increased—Betamethasone—psoriatic arthritis	0.000228	0.000825	CcSEcCtD
Lamivudine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000228	0.000825	CcSEcCtD
Lamivudine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000228	0.000823	CcSEcCtD
Lamivudine—Insomnia—Prednisone—psoriatic arthritis	0.000227	0.000822	CcSEcCtD
Lamivudine—Paraesthesia—Prednisone—psoriatic arthritis	0.000226	0.000816	CcSEcCtD
Lamivudine—Pruritus—Triamcinolone—psoriatic arthritis	0.000225	0.000813	CcSEcCtD
Lamivudine—Cough—Methotrexate—psoriatic arthritis	0.000225	0.000812	CcSEcCtD
Lamivudine—Pruritus—Methylprednisolone—psoriatic arthritis	0.000225	0.000812	CcSEcCtD
Lamivudine—Convulsion—Methotrexate—psoriatic arthritis	0.000223	0.000806	CcSEcCtD
Lamivudine—Dyspepsia—Prednisone—psoriatic arthritis	0.000221	0.0008	CcSEcCtD
Lamivudine—Chest pain—Methotrexate—psoriatic arthritis	0.000219	0.000792	CcSEcCtD
Lamivudine—Myalgia—Methotrexate—psoriatic arthritis	0.000219	0.000792	CcSEcCtD
Lamivudine—Arthralgia—Methotrexate—psoriatic arthritis	0.000219	0.000792	CcSEcCtD
Lamivudine—Decreased appetite—Prednisone—psoriatic arthritis	0.000219	0.00079	CcSEcCtD
Lamivudine—Rash—Prednisolone—psoriatic arthritis	0.000218	0.000788	CcSEcCtD
Lamivudine—Dermatitis—Prednisolone—psoriatic arthritis	0.000218	0.000788	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000218	0.000787	CcSEcCtD
Lamivudine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000217	0.000785	CcSEcCtD
Lamivudine—Fatigue—Prednisone—psoriatic arthritis	0.000217	0.000783	CcSEcCtD
Lamivudine—Headache—Prednisolone—psoriatic arthritis	0.000217	0.000783	CcSEcCtD
Lamivudine—Discomfort—Methotrexate—psoriatic arthritis	0.000217	0.000783	CcSEcCtD
Lamivudine—Constipation—Prednisone—psoriatic arthritis	0.000215	0.000777	CcSEcCtD
Lamivudine—Confusional state—Methotrexate—psoriatic arthritis	0.000212	0.000766	CcSEcCtD
Lamivudine—Dizziness—Triamcinolone—psoriatic arthritis	0.00021	0.00076	CcSEcCtD
Lamivudine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00021	0.000759	CcSEcCtD
Lamivudine—Dizziness—Methylprednisolone—psoriatic arthritis	0.00021	0.000759	CcSEcCtD
Lamivudine—Infection—Methotrexate—psoriatic arthritis	0.000209	0.000754	CcSEcCtD
Lamivudine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000207	0.000749	CcSEcCtD
Lamivudine—Asthenia—Dexamethasone—psoriatic arthritis	0.000207	0.000748	CcSEcCtD
Lamivudine—Asthenia—Betamethasone—psoriatic arthritis	0.000207	0.000748	CcSEcCtD
Lamivudine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000206	0.000745	CcSEcCtD
Lamivudine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000206	0.000743	CcSEcCtD
Lamivudine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000206	0.000743	CcSEcCtD
Lamivudine—Nausea—Prednisolone—psoriatic arthritis	0.000206	0.000743	CcSEcCtD
Lamivudine—Pruritus—Dexamethasone—psoriatic arthritis	0.000204	0.000738	CcSEcCtD
Lamivudine—Pruritus—Betamethasone—psoriatic arthritis	0.000204	0.000738	CcSEcCtD
Lamivudine—Skin disorder—Methotrexate—psoriatic arthritis	0.000204	0.000737	CcSEcCtD
Lamivudine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000203	0.000734	CcSEcCtD
Lamivudine—Vomiting—Triamcinolone—psoriatic arthritis	0.000202	0.000731	CcSEcCtD
Lamivudine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000202	0.000729	CcSEcCtD
Lamivudine—Rash—Triamcinolone—psoriatic arthritis	0.000201	0.000725	CcSEcCtD
Lamivudine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000201	0.000724	CcSEcCtD
Lamivudine—Anorexia—Methotrexate—psoriatic arthritis	0.0002	0.000724	CcSEcCtD
Lamivudine—Rash—Methylprednisolone—psoriatic arthritis	0.0002	0.000723	CcSEcCtD
Lamivudine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.0002	0.000723	CcSEcCtD
Lamivudine—Urticaria—Prednisone—psoriatic arthritis	0.0002	0.000722	CcSEcCtD
Lamivudine—Headache—Triamcinolone—psoriatic arthritis	0.000199	0.00072	CcSEcCtD
Lamivudine—Headache—Methylprednisolone—psoriatic arthritis	0.000199	0.000719	CcSEcCtD
Lamivudine—Abdominal pain—Prednisone—psoriatic arthritis	0.000199	0.000718	CcSEcCtD
Lamivudine—Body temperature increased—Prednisone—psoriatic arthritis	0.000199	0.000718	CcSEcCtD
Lamivudine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000198	0.000714	CcSEcCtD
Lamivudine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000198	0.000714	CcSEcCtD
Lamivudine—Hypotension—Methotrexate—psoriatic arthritis	0.000196	0.000709	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000192	0.000692	CcSEcCtD
Lamivudine—Dizziness—Betamethasone—psoriatic arthritis	0.000191	0.00069	CcSEcCtD
Lamivudine—Dizziness—Dexamethasone—psoriatic arthritis	0.000191	0.00069	CcSEcCtD
Lamivudine—Insomnia—Methotrexate—psoriatic arthritis	0.00019	0.000687	CcSEcCtD
Lamivudine—Nausea—Triamcinolone—psoriatic arthritis	0.000189	0.000683	CcSEcCtD
Lamivudine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000189	0.000682	CcSEcCtD
Lamivudine—Nausea—Methylprednisolone—psoriatic arthritis	0.000189	0.000681	CcSEcCtD
Lamivudine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000187	0.000677	CcSEcCtD
Lamivudine—Somnolence—Methotrexate—psoriatic arthritis	0.000187	0.000675	CcSEcCtD
Lamivudine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000185	0.000669	CcSEcCtD
Lamivudine—Dyspepsia—Methotrexate—psoriatic arthritis	0.000185	0.000668	CcSEcCtD
Lamivudine—Vomiting—Dexamethasone—psoriatic arthritis	0.000184	0.000663	CcSEcCtD
Lamivudine—Vomiting—Betamethasone—psoriatic arthritis	0.000184	0.000663	CcSEcCtD
Lamivudine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000183	0.00066	CcSEcCtD
Lamivudine—Rash—Dexamethasone—psoriatic arthritis	0.000182	0.000658	CcSEcCtD
Lamivudine—Rash—Betamethasone—psoriatic arthritis	0.000182	0.000658	CcSEcCtD
Lamivudine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000182	0.000657	CcSEcCtD
Lamivudine—Dermatitis—Betamethasone—psoriatic arthritis	0.000182	0.000657	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000181	0.000655	CcSEcCtD
Lamivudine—Fatigue—Methotrexate—psoriatic arthritis	0.000181	0.000655	CcSEcCtD
Lamivudine—Headache—Dexamethasone—psoriatic arthritis	0.000181	0.000654	CcSEcCtD
Lamivudine—Headache—Betamethasone—psoriatic arthritis	0.000181	0.000654	CcSEcCtD
Lamivudine—Asthenia—Prednisone—psoriatic arthritis	0.00018	0.000652	CcSEcCtD
Lamivudine—Pain—Methotrexate—psoriatic arthritis	0.00018	0.000649	CcSEcCtD
Lamivudine—Pruritus—Prednisone—psoriatic arthritis	0.000178	0.000643	CcSEcCtD
Lamivudine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000173	0.000626	CcSEcCtD
Lamivudine—Diarrhoea—Prednisone—psoriatic arthritis	0.000172	0.000622	CcSEcCtD
Lamivudine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000172	0.000621	CcSEcCtD
Lamivudine—Nausea—Betamethasone—psoriatic arthritis	0.000172	0.00062	CcSEcCtD
Lamivudine—Nausea—Dexamethasone—psoriatic arthritis	0.000172	0.00062	CcSEcCtD
Lamivudine—Urticaria—Methotrexate—psoriatic arthritis	0.000167	0.000603	CcSEcCtD
Lamivudine—Dizziness—Prednisone—psoriatic arthritis	0.000166	0.000601	CcSEcCtD
Lamivudine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000166	0.0006	CcSEcCtD
Lamivudine—Body temperature increased—Methotrexate—psoriatic arthritis	0.000166	0.0006	CcSEcCtD
Lamivudine—Vomiting—Prednisone—psoriatic arthritis	0.00016	0.000578	CcSEcCtD
Lamivudine—Rash—Prednisone—psoriatic arthritis	0.000159	0.000573	CcSEcCtD
Lamivudine—Dermatitis—Prednisone—psoriatic arthritis	0.000158	0.000572	CcSEcCtD
Lamivudine—Headache—Prednisone—psoriatic arthritis	0.000158	0.000569	CcSEcCtD
Lamivudine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000155	0.000559	CcSEcCtD
Lamivudine—Asthenia—Methotrexate—psoriatic arthritis	0.000151	0.000545	CcSEcCtD
Lamivudine—Nausea—Prednisone—psoriatic arthritis	0.000149	0.00054	CcSEcCtD
Lamivudine—Pruritus—Methotrexate—psoriatic arthritis	0.000149	0.000537	CcSEcCtD
Lamivudine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000144	0.000519	CcSEcCtD
Lamivudine—Dizziness—Methotrexate—psoriatic arthritis	0.000139	0.000502	CcSEcCtD
Lamivudine—Vomiting—Methotrexate—psoriatic arthritis	0.000134	0.000483	CcSEcCtD
Lamivudine—Rash—Methotrexate—psoriatic arthritis	0.000133	0.000479	CcSEcCtD
Lamivudine—Dermatitis—Methotrexate—psoriatic arthritis	0.000132	0.000478	CcSEcCtD
Lamivudine—Headache—Methotrexate—psoriatic arthritis	0.000132	0.000476	CcSEcCtD
Lamivudine—Nausea—Methotrexate—psoriatic arthritis	0.000125	0.000451	CcSEcCtD
